🧬 Terminal Transferase (TdT) Enzymatic DNA Printing

Cell-Free Enzymatic DNA Synthesis Foundry Model

Underwrite continuous microfluidic enzymatic DNA printers utilizing engineered Terminal Deoxynucleotidyl Transferase (TdT) synthesizing gene-length 10,000 bp constructs without toxic phosphoramidite reagents. Model synthetic biology CDMO contracts ($0.08/bp), and 20-yr IRR.

1. Capacity & Unit Economics

2. Financial Returns & Yield

10kb ENZYMATIC GENE PRINTING
Annual Net EBITDA
$0 / yr
20-Yr Project IRR
0.0%
Gross Revenue
$0 / yr
Total CapEx
$0
Annual OpEx
$0 / yr